Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Albert SM
Alzheimer Disease
ObsRO
Albert SM, Castillo-Castaneda C, Jacobs DM, Sano M, Bell K, Merchant C, Small S, Stern Y. Proxy-reported quality of life in Alzheimer’s patients: Comparison of clinical and population-based samples. J Mental Health and Aging, 5(1), 49-58, 1999
Albert SM, Castillo-Castaneda C, Jacobs DM, Sano M, Marder K, Bell K, Devanand D, Brandt J, Albert M, Stern Y. Longitudinal study of quality of life in people with advanced Alzheimer’s disease. Amer J Geriatric Psychiatry, 9(2): 160-168, 2001
Albert SM. Quality of life in advanced dementia. Research and Practice in Alzheimer's Disease 2002; 6: 131-135
Albert SM
Professor and Associate Chair
Department of Behavioral & Community Health Sciences
Graduate School of Public Health
University of Pittsburgh
A211 Crabtree, 130 DeSoto St.
Pittsburgh, PA 15261
USA
Phone: +1 (412) 383-8693
Fax: +1 (412) 383-5846
E-mail: smalbert@pitt.edu
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
If you do not receive specific funding for your study, you may download the questionnaire directly:
Tutorials are available on our FAQs.
All requests have to be submitted through our online request management:
| ROYALTY FEES* | Commercial users | Cost per study | 500 USD |
| Cost per language | 500 USD | ||
| Funded academic research | Cost per study | Free | |
| Cost per language | Free | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
| DISTRIBUTION FEES* | Commercial users | Cost per study | 800 € |
| Cost per language | 300 € | ||
| Funded academic research | Cost per study | 300 € | |
| Cost per language | 50 € | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
Should you not correspond to this category of users, please send us a request.
Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.
If you are interested in specific language(s), please first consult the list of existing translations in PROQOLID.
To access this section, please complete a client account.
The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.
The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
Subscribe to PROQOLID™
And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!
SubscribePurchase a limited access to this COA instrument page
This will allow you to view this specific COA page during one active session of 12 hours max starting at your first attempt. Note that if your session is inactive for four hours, your access will be closed.